دورية أكاديمية

Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia.

التفاصيل البيبلوغرافية
العنوان: Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia.
المؤلفون: Hayashi T; Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan., Kanno SI; Division of Clinical Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan., Watanabe C; Division of Physiology and Anatomy, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan., Scuteri D; Department of Health Sciences, University 'Magna Graecia' of Catanzaro, 88100 Catanzaro, Italy., Agatsuma Y; Division of Pharmaceutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan., Hara A; Division of Clinical Pharmacotherapeutics, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan., Bagetta G; Pharmacotechnology Documentation & Transfer Unit, Department of Pharmacy, Preclinical & Translational Pharmacology, Health & Nutritional Sciences, University of Calabria, 87036 Rende, Italy., Sakurada T; Faculty of Pharmacy, Daiichi University of Pharmacy, Fukuoka 815-8511, Japan., Sakurada S; Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan.
المصدر: Biomedicines [Biomedicines] 2024 Jun 15; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 15.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: A complication of diabetes is neuropathic pain, which is difficult to control with medication. We have confirmed that neuropathic pain due to mechanical allodynia in diabetic mice is mediated by a characteristic neuropeptide in the spinal cord. We evaluated the strength of mechanical allodynia in mice using von Frey filaments. When mice were intravenously injected with streptozotocin, mechanical allodynia appeared 3 days later. Antibodies of representative neuropeptides were intrathecally (i.t.) administered to allodynia-induced mice 7 days after the intravenous administration of streptozotocin, and allodynia was reduced by anti-cholecystokinin octapeptide antibodies, anti-nociceptin/orphanin FQ antibodies, and anti-hemokinin-1 antibodies. In contrast, i.t.-administered anti-substance P antibodies, anti-somatostatin antibodies, and anti-angiotensin II antibodies did not affect streptozotocin-induced diabetic allodynia mice. Mechanical allodynia was attenuated by the i.t. administration of CCK-B receptor antagonists and ORL-1 receptor antagonists. The mRNA level of CCK-B receptors in streptozotocin-induced diabetic allodynia mice increased in the spinal cord, but not in the dorsal root ganglion. These results indicate that diabetic allodynia is caused by cholecystokinin octapeptide, nociceptin/orphanin FQ, and hemokinin-1 released from primary afferent neurons in the spinal cord that transmit pain to the brain via the spinal dorsal horn.
References: Neurosci Lett. 2012 Jan 6;506(1):104-6. (PMID: 22075222)
Am J Physiol. 1995 Nov;269(5 Pt 1):G628-46. (PMID: 7491953)
Eur J Pharmacol. 2014 Oct 15;741:264-71. (PMID: 25169429)
Neuropharmacology. 2003 Aug;45(2):242-50. (PMID: 12842130)
Prog Neurobiol. 1999 Apr;57(5):485-505. (PMID: 10215098)
Neurosci Lett. 2016 Mar 23;617:236-9. (PMID: 26899156)
FEBS Lett. 1994 Mar 14;341(1):33-8. (PMID: 8137918)
J Comp Neurol. 1998 Sep 28;399(3):373-83. (PMID: 9733084)
Mol Pharmacol. 2016 Sep;90(3):205-13. (PMID: 27401876)
Int J Mol Sci. 2020 Apr 22;21(8):. (PMID: 32331300)
Neuropharmacology. 2000 Jun 8;39(8):1337-56. (PMID: 10818251)
Nature. 1995 Oct 12;377(6549):532-5. (PMID: 7566152)
Neuropeptides. 2002 Apr-Jun;36(2-3):157-70. (PMID: 12359506)
Atherosclerosis. 2007 Apr;191(2):241-9. (PMID: 16979174)
Pain. 2000 Sep;87(3):265-273. (PMID: 10963906)
Front Pharmacol. 2021 Jan 13;11:594479. (PMID: 33519457)
Prog Neurobiol. 1999 Jul;58(4):349-79. (PMID: 10368033)
Cell Signal. 1997 Jan;9(1):1-13. (PMID: 9067625)
Neuroscience. 1993 Nov;57(2):227-33. (PMID: 8115034)
Brain Res. 2001 Jun 8;903(1-2):128-40. (PMID: 11382396)
J Comp Neurol. 1996 Apr 29;368(2):229-51. (PMID: 8725304)
Science. 1976 Jul 30;193(4251):415-7. (PMID: 180605)
Pain Med. 2007 Sep;8 Suppl 2:S50-62. (PMID: 17714116)
Can J Vet Res. 2004 Apr;68(2):86-92. (PMID: 15188951)
Nat Immunol. 2000 Nov;1(5):392-7. (PMID: 11062498)
Eur J Pharmacol. 2001 Sep 21;427(3):203-10. (PMID: 11567650)
Front Pharmacol. 2020 Oct 29;11:590918. (PMID: 33250769)
Br J Dermatol. 2019 Nov;181(5):932-938. (PMID: 31016733)
Brain Res. 2001 Feb 23;892(2):370-5. (PMID: 11172785)
Diabetes Obes Metab. 2015 Dec;17(12):1115-25. (PMID: 26179288)
Pain. 2006 May;122(1-2):118-25. (PMID: 16527403)
Science. 1995 Nov 3;270(5237):792-4. (PMID: 7481766)
Eur J Pharmacol. 2017 Apr 5;800:9-15. (PMID: 28131781)
Neuroreport. 2003 Mar 3;14(3):431-6. (PMID: 12634498)
J Pharm Pharmacol. 2005 Dec;57(12):1575-80. (PMID: 16354401)
Br J Pharmacol. 2008 Nov;155(5):767-74. (PMID: 18660829)
Eur J Pharmacol. 1980 Oct 17;67(2-3):313-6. (PMID: 6893963)
Eur J Pharmacol. 2005 Mar 14;510(3):223-8. (PMID: 15763246)
Semin Neurol. 2015 Aug;35(4):458-68. (PMID: 26502768)
Pain Med. 2008 Sep;9(6):660-74. (PMID: 18828198)
Brain Res. 1986 Jan 1;362(1):175-9. (PMID: 3002550)
Brain Res Bull. 2019 Apr;147:165-173. (PMID: 30664920)
Neuropeptides. 2017 Aug;64:9-17. (PMID: 27993375)
Eur J Pharmacol. 2014 Apr 5;728:59-66. (PMID: 24508519)
فهرسة مساهمة: Keywords: cholecystokinin octapeptide; diabetic allodynia; hemokinin-1; nociceptin/orphanin FQ; spinal cord
تواريخ الأحداث: Date Created: 20240627 Latest Revision: 20240629
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11202074
DOI: 10.3390/biomedicines12061332
PMID: 38927539
قاعدة البيانات: MEDLINE
الوصف
تدمد:2227-9059
DOI:10.3390/biomedicines12061332